Literature DB >> 2985340

Lung cancer and pleural effusion. Clinical significance and study of pleural metastatic locations.

A Cantó, G Ferrer, V Romagosa, J Moya, R Bernat.   

Abstract

We reviewed results of 78 diagnostic thoracoscopic examinations of patients with lung cancer and homolateral pleural effusion. The study stresses the main locations of pleural metastasis in cases of lung cancer and correlates these data with the pleural spread from extrathoracic primary neoplasms. Also pointed out is the operability of the present series and the different behavior in pleural metastatic spread according to the histologic type with correlation between gross appearance of the effusion and the cytology.

Entities:  

Mesh:

Year:  1985        PMID: 2985340     DOI: 10.1378/chest.87.5.649

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.

Authors:  Susana Herrera Lara; Estrella Fernández-Fabrellas; Gustavo Juan Samper; Josefa Marco Buades; Rafael Andreu Lapiedra; Amparo Pinilla Moreno; María Morales Suárez-Varela
Journal:  Lung       Date:  2017-06-27       Impact factor: 2.584

Review 2.  Lung metastases.

Authors:  C J Herold; A A Bankier; D Fleischmann
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 3.  Video assisted thoracoscopic and open chest surgery in diagnosis and treatment of malignant pleural diseases.

Authors:  Periklis Perikleous; David A Waller
Journal:  J Vis Surg       Date:  2017-06-22

Review 4.  Prognostic impact of pleural effusion in patients with malignancy: A systematic review and meta-analysis.

Authors:  Yuan Yang; Juan Du; Yi-Shan Wang; Han-YuJie Kang; Kan Zhai; Huan-Zhong Shi
Journal:  Clin Transl Sci       Date:  2022-03-21       Impact factor: 4.438

5.  Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma.

Authors:  Dan Liu; Yachao Lu; Zhenli Hu; Ning Wu; Xiaomeng Nie; Yang Xia; Yiping Han; Qiang Li; Guanshan Zhu; Chong Bai
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.